ALKERMES | ALKS - Crediti Commerciali

Prezzo Delle Azioni
33.70
Cambio Giornaliero
-0.01 -0.03%
Mensile
-4.69%
Annuale
10.20%
Q2 Previsione
32.32




Crediti Commerciali Cambiamento Data
AbbVie USD 12.59B 180M 2025-12
Acadia Pharmaceuticals USD 148.23M 8.79M 2025-12
ALKERMES USD 334.02M 21.08M 2025-12
Amgen USD 9.14B 432M 2026-03
Biogen USD 1.79B 76.6M 2026-03
BioMarin Pharmaceutical USD 908.21M 117.95M 2025-12
Bristol-Myers Squibb USD 14.36B 164M 2026-03
Coherus Biosciences USD 18.42M 232.08M 2025-12
Eli Lilly USD 21.18B 1.02B 2026-03
Gilead Sciences USD 4.91B 182M 2025-12
Heron Therapeutics USD 89.59M 8.54M 2025-12
Ionis Pharmaceuticals USD 74M 8M 2026-03
J&J USD 21.33B 3.72B 2025-12
Malin Corporation EUR 500K 300K 2024-12
Merck USD 11.78B 345M 2025-12
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
Otsuka Holdings JPY 537.37B 32.95B 2026-03
Ovoca Bio EUR 39K 408K 2025-06
Pfizer USD 18.12B 2.02B 2025-09
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12